Concepedia

Marshall Freedman

MF

Statistics

Publications

3

Citations

220

H-Index

3

Active since

2008

Affiliations

GlaxoSmithKline (United States)(Current)

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

GlaxoSmithKline (Belgium)

Marshall Freedman is an author at GlaxoSmithKline (United States) specializing in vaccinology, vaccine-preventable diseases, and herpes zoster vaccination.

Publications per year

2008–2022

3

Publications

3

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 101 citations · Full text

, , +17

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 93 citations · Full text

, , +17

AUTOMATED SCORING OF SHORT‐ANSWER OPEN‐ENDED GRE<sup>®</sup> SUBJECT TEST ITEMS

Yigal Attali, Don Powers, Marshall Freedman et al. · ETS Research Report Series · 2008 · 26 citations

, , +12

1–3 of 3